StockSelector.com
  Research, Select, & Monitor Sunday, September 23, 2018 10:53:25 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
ACADIA Pharmaceuticals Inc.$20.17$1.065.55%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

ACADIA Pharmaceuticals Inc. has an overall rank of 5914 out of 7243 stocks based on 8 positive rankings and 10 negative rankings.

Positive Rankings
10 Day Gain
ACADIA Pharmaceuticals Inc. rank is 72
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, ACADIA Pharmaceuticals Inc. is ranked 88.
Historic Revenue Growth
ACADIA Pharmaceuticals Inc. rank is 92
Estimated Revenue Growth
ACADIA Pharmaceuticals Inc. rank is 135
Low Put/Call
ACADIA Pharmaceuticals Inc. has a low Put/Call ratio of 0.11 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, ACADIA Pharmaceuticals Inc. is ranked 285.
Debt-to-Equity
ACADIA Pharmaceuticals Inc. rank is 306
Low vPut/Call
ACADIA Pharmaceuticals Inc. has a low Put/Call ratio of 0.19 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, ACADIA Pharmaceuticals Inc. is ranked 469.
90 Day Gain
ACADIA Pharmaceuticals Inc. rank is 1644
Negative Rankings
Overbought RSI
The 14 Day Relative-Strength Index for ACADIA Pharmaceuticals Inc. is 84.2. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, ACADIA Pharmaceuticals Inc. is ranked 49.
Negative Guidance
Within the past 90 days ACADIA Pharmaceuticals Inc. has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Overbought Stochastics
ACADIA Pharmaceuticals Inc. rank is 282
Negative ROA
ACADIA Pharmaceuticals Inc. rank is 367
Negative ROE
ACADIA Pharmaceuticals Inc. rank is 392
Price-to-Sales
ACADIA Pharmaceuticals Inc. rank is 420
Negative Net Margin
ACADIA Pharmaceuticals Inc. rank is 436
Down EPS Surprise
ACADIA Pharmaceuticals Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
ACADIA Pharmaceuticals Inc. rank is 679
Negative Cash Growth
ACADIA Pharmaceuticals Inc. rank is 1154







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.